Wareef Kabbani
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
-
- Renal cell carcinoma treatment
Papers in
- Surgery 17
- Bladder and Urothelial Cancer Treatments 9
- Urinary and Genital Oncology Studies 3
-
- Renal and related cancers 3
- Epigenetics and DNA Methylation 2
- Co-authors
- Jeffrey A. Cadeddu (17 shared papers)Jer‐Tsong Hsieh (8 shared papers)Yair Lotan (20 shared papers)Jennifer Stanfield (4 shared papers)Joshua M. Stern (2 shared papers)David A. Boothman (4 shared papers)James Brugarolas (4 shared papers)Nicholas C. Wolff (3 shared papers)
- Journals
- The Journal of Urology (14 papers)British Journal of Urology (7 papers)Urology (4 papers)Journal of Clinical Oncology (3 papers)The Prostate (2 papers)
- Partner nations
- United StatesEgyptChina
In The Last Decade
Wareef Kabbani
55 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 108
- Toxicology 107
- Pulmonary and Respiratory Medicine 415
- Reproductive Medicine 89
- Surgery 419
- Cancer Research 138
Countries citing papers authored by Wareef Kabbani
This map shows the geographic impact of Wareef Kabbani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wareef Kabbani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wareef Kabbani more than expected).
Fields of papers citing papers by Wareef Kabbani
This network shows the impact of papers produced by Wareef Kabbani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wareef Kabbani. The network helps show where Wareef Kabbani may publish in the future.
Co-authors
The 25 scholars most cited alongside Wareef Kabbani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 194 | |
| 2 | 2007 | 184 | |
| 3 | 2002 | 100 | |
| 4 | 2011 | 88 | |
| 5 | 2010 | 75 | |
| 6 | 2010 | 70 | |
| 7 | 2008 | 67 | |
| 8 | 2008 | 64 | |
| 9 | 2010 | 63 | |
| 10 | 2011 | 63 | |
| 11 | 2006 | 57 | |
| 12 | 2011 | 52 | |
| 13 | 2010 | 49 | |
| 14 | 2008 | 47 | |
| 15 | 2003 | 39 | |
| 16 | 2010 | 38 | |
| 17 | 2014 | 32 | |
| 18 | 2009 | 31 | |
| 19 | 2010 | 26 | |
| 20 | 2005 | 24 |
About Wareef Kabbani
Wareef Kabbani is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Reproductive Medicine, having authored 58 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (9 papers), Renal cell carcinoma treatment (5 papers), Renal and related cancers (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Urinary and Genital Oncology Studies (3 papers), Tuberous Sclerosis Complex Research (3 papers), Cervical Cancer and HPV Research (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Toxicology (107 citations), Pulmonary and Respiratory Medicine (415 citations), Reproductive Medicine (89 citations), Surgery (419 citations) and Cancer Research (138 citations). Wareef Kabbani has collaborated with scholars based in United States, Egypt and China. Frequent co-authors include Jeffrey A. Cadeddu, Jer‐Tsong Hsieh, Yair Lotan, Jennifer Stanfield, Joshua M. Stern, David A. Boothman, James Brugarolas, Nicholas C. Wolff, Xian‐Jin Xie and Chad R. Tracy. Their work appears in journals such as The Journal of Urology, British Journal of Urology, Urology, Journal of Clinical Oncology and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.